FBTvsREW
FIRST TRUST NYSE ARCA BIOTECHNOLOGY INDEX FUND against ProShares UltraShort Technology — the fee, the flows, the book, and a year head-to-head.
Head to head
| FBT | REW | |
|---|---|---|
| Expense ratio | — | 0.95% |
| Assets | $1.2B | $3875.11T |
| Net flow, 1 month | — | +$930 |
| Net flow, 1 year | — | +$4K |
| Return, YTD | +29.0% | -55.0% |
| Return, 1 year | +42.5% | -56.7% |
| Avg daily volume | 78K | 49K |
| Holdings | 31 | 9 |
| Listed | Nov 8, 2023 | Feb 2, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS